Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially

International Immunopharmacology

Volumn 26, Issue 2, 2015, Pages 314-321

  Zhao, Wenxiu ^a   Xu, Yaping ^a   Xu, Jianfeng ^a   Wu, Duan ^a   Zhao, Bixing ^a   Yin, Zhenyu ^a   Wang, Xiaomin ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Chemokine receptors; Chemokines; Hepatocellular carcinoma; Myeloid derived suppressor cells

Indexed keywords

CHEMOKINE; CHEMOKINE LIGAND 12; CHEMOKINE LIGAND 19; CHEMOKINE LIKE RECEPTOR 1; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR6; CKLF LIKE MARVEL TRANSMEMBRANE DOMAIN CONTAINING 3; CXCL16 CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CXCR1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CHEMOTAXIS; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SUPPRESSOR CELL; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LIVER TUMOR; METABOLISM; MONOCYTE; NEUTROPHIL; TUMOR ESCAPE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; CHEMOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNE TOLERANCE; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MONOCYTES; MYELOID CELLS; NEUTROPHILS; RECEPTORS, CCR2; RECEPTORS, INTERLEUKIN-8A; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 84928409380     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.04.010     Document Type: Article

References (36)

1. M.D. Vesely, M.H. Kershaw, R.D. Schreiber, and M.J. Smyth Natural innate and adaptive immunity to cancer Annu. Rev. Immunol. 29 2011 235 271
2. N. Mukaida, S. Sasaki, and T. Baba Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment Mediat. Inflamm. 2014 2014 170381
3. J. Zhou, Y. Xiang, T. Yoshimura, K. Chen, W. Gong, and J. Huang The role of chemoattractant receptors in shaping the tumor microenvironment BioMed Res. Int. 2014 2014 751392
4. S. Ostrand-Rosenberg, and P. Sinha Myeloid-derived suppressor cells: linking inflammation and cancer J. Immunol. 182 2009 4499 4506
5. S. Ostrand-Rosenberg Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity Cancer Immunol. Immunother. 59 2010 1593 1600
6. B. Almand, J.I. Clark, E. Nikitina, J. van Beynen, N.R. English, and S.C. Knight Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer J. Immunol. 166 2001 678 689
7. D.I. Gabrilovich, and S. Nagaraj Myeloid-derived suppressor cells as regulators of the immune system Nat. Rev. Immunol. 9 2009 162 174
8. K. Movahedi, M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, and A. Beschin Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity Blood 111 2008 4233 4244
9. J.I. Youn, S. Nagaraj, M. Collazo, and D.I. Gabrilovich Subsets of myeloid-derived suppressor cells in tumor-bearing mice J. Immunol. 181 2008 5791 5802
10. Z. Zhou, D.L. French, G. Ma, S. Eisenstein, Y. Chen, and C.M. Divino Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells Stem Cells 28 2010 620 632
11. B. Huang, Z. Lei, J. Zhao, W. Gong, J. Liu, and Z. Chen CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers Cancer Lett. 252 2007 86 92
12. Y. Sawanobori, S. Ueha, M. Kurachi, T. Shimaoka, J.E. Talmadge, and J. Abe Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice Blood 111 2008 5457 5466
13. S.L. Highfill, Y. Cui, A.J. Giles, J.P. Smith, H. Zhang, and E. Morse Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy Sci. Transl. Med. 6 2014 237ra67
14. Y. Zhang, D. Lv, H.J. Kim, R.A. Kurt, W. Bu, and Y. Li A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells Cell Res. 23 2013 394 408
15. A.A. Keskinov, and M.R. Shurin Myeloid regulatory cells in tumor spreading and metastasis Immunobiology 220 2015 236 242
16. A.M. Lesokhin, T.M. Hohl, S. Kitano, C. Cortez, D. Hirschhorn-Cymerman, and F. Avogadri Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment Cancer Res. 72 2012 876 886
17. S.K. Bromley, T.R. Mempel, and A.D. Luster Orchestrating the orchestrators: chemokines in control of T cell traffic Nat. Immunol. 9 2008 970 980
18. A. Zlotnik, and O. Yoshie Chemokines: a new classification system and their role in immunity Immunity 12 2000 121 127
19. P. Allavena, and A. Mantovani Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment Clin. Exp. Immunol. 167 2012 195 205
20. A. Mantovani The growing diversity and spectrum of action of myeloid-derived suppressor cells Eur. J. Immunol. 40 2010 3317 3320
21. D.I. Gabrilovich, S. Ostrand-Rosenberg, and V. Bronte Coordinated regulation of myeloid cells by tumours Nat. Rev. Immunol. 12 2012 253 268
22. W. Wang, Z. Jiao, T. Duan, M. Liu, B. Zhu, and Y. Zhang Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis Eur. J. Immunol. 45 2015 464 473
23. J. Deshane, J.W. Zmijewski, R. Luther, A. Gaggar, R. Deshane, and J.F. Lai Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness Mucosal Immunol. 4 2011 503 518
24. H. Katoh, D. Wang, T. Daikoku, H. Sun, S.K. Dey, and R.N. Dubois CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis Cancer Cell 24 2013 631 644
25. T. Condamine, Ramachandran I Fau - Youn J-I, D.I. Youn Ji Fau - Gabrilovich, and D.I. Gabrilovich Regulation of tumor metastasis by myeloid-derived suppressor cells Annu. Rev. Med. 66 2015 97 110
26. E. Schlecker, A. Stojanovic, C. Eisen, C. Quack, C.S. Falk, and V. Umansky Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth J. Immunol. 189 2012 5602 5611
27. S.A. Luther, and J.G. Cyster Chemokines as regulators of T cell differentiation Nat. Immunol. 2 2001 102 107
28. M. Elkabets, V.S. Ribeiro, C.A. Dinarello, S. Ostrand-Rosenberg, J.P. Di Santo, and R.N. Apte IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function Eur. J. Immunol. 40 2010 3347 3357
29. S. Tu, G. Bhagat, G. Cui, S. Takaishi, E.A. Kurt-Jones, and B. Rickman Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice Cancer Cell 14 2008 408 419
30. M. Bruchard, G. Mignot, V. Derangere, F. Chalmin, A. Chevriaux, and F. Vegran Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth Nat. Med. 19 2013 57 64
31. S.K. Bunt, L. Yang, P. Sinha, V.K. Clements, J. Leips, and S. Ostrand-Rosenberg Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression Cancer Res. 67 2007 10019 10026
32. K. Oh, O.-Y. Lee, S.Y. Shon, O. Nam, P.M. Ryu, and M.W. Seo A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model Breast Cancer Res. 15 2013 R79-R
33. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
34. F. Balkwill TNF-alpha in promotion and progression of cancer Cancer Metastasis Rev. 25 2006 409 416
35. X. Zhao, L. Rong, X. Zhao, X. Li, X. Liu, and J. Deng TNF signaling drives myeloid-derived suppressor cell accumulation J. Clin. Invest. 122 2012 4094 4104
36. X. Hu, B. Li, X. Li, X. Zhao, L. Wan, and G. Lin Transmembrane TNF-alpha promotes suppressive activities of myeloid-derived suppressor cells via TNFR2 J. Immunol. 192 2014 1320 1331